Related Experiment Video
Updated: Jul 23, 2025
05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.7K
From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?
Mu Guo1,2, Xiangbin Yu1,2, Yi Zhun Zhu3
1School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Molecules (Basel, Switzerland)
|July 14, 2023
Summary
Imidazothiazole derivatives show significant therapeutic potential with diverse physiological activities. This review highlights their antitumor, anti-infection, anti-inflammatory, and antioxidant effects, guiding future drug development.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Imidazothiazole derivatives are gaining prominence in therapeutics.
- These compounds exhibit notable physiological activities.
Purpose of the Study:
- To review the pharmacological effects of imidazothiazole derivatives.
- To summarize their mechanisms of action.
- To guide future drug development.
Main Methods:
- Literature review of imidazothiazole derivatives.
- Analysis of reported biological activities.
- Synthesis of pharmacological data.
Main Results:
- Imidazothiazole derivatives possess antitumor properties.
- They demonstrate anti-infection, anti-inflammatory, and antioxidant effects.
- Various derivatives exhibit distinct pharmacological profiles.
Conclusions:
- Imidazothiazole derivatives are versatile scaffolds for drug discovery.
- Understanding their mechanisms is crucial for therapeutic advancement.
- This review provides a foundation for developing novel imidazothiazole-based drugs.
Related Concept Videos
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
754
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
754
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
346
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
346
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
249
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
249
01:26Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
204
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
204
01:26Drug Administration and Therapy Phases: Overview
555
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
555